secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCorRx Inc. (BICX)
CIK:        0001443863
Form:       8-K
Filed at:   2022-10-27T23:59:59+00:00
Accession:  0001477932-22-007951
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCorRx changes independent auditor to Marcum LLP after Friedman merger
------------------------------------------------------------------------

- Friedman LLP combined with Marcum LLP effective Sept 1, 2022; BOD engaged Marcum LLP on Oct 21, 2022 for FY2022 audit.
- Friedman's audit reports for 2020 and 2021 included a going concern explanatory paragraph; no adverse opinions or modifications.
- No disagreements or reportable events during the two most recent fiscal years or subsequent interim period before Friedman's merger.
- Friedman formally resigned as independent registered public accounting firm on October 21, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1443863/000147793222007951/0001477932-22-007951-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1443863/000147793222007951/bicx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-22-007951

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer